Replacement of Asp-162 by Ala prevents the cooperative transition by the substrates while enhancing the effect of the allosteric activator ATP on E. coli aspartate transcarbamoylase.
The available crystal structures of Escherichia coli aspartate transcarbamoylase (ATCase) show that the conserved residue Asp-162 from the catalytic chain interacts with essentially the same residues in both the T- and R-states. To study the role of Asp-162 in the regulatory properties of the enzyme, this residue has been replaced by alanine. The mutant D162A shows a 7700-fold reduction in the maximal observed specific activity, a twofold decrease in the affinity for aspartate, a loss of homotropic cooperativity, and decreased activation by the nucleotide effector adenosine triphosphate (ATP) compared with the wild-type enzyme. Small-angle X-ray scattering (SAXS) measurements reveal that the unliganded mutant enzyme adopts the T-quaternary structure of the wild-type enzyme. Most strikingly, the bisubstrate analog N-phosphonacetyl-L-aspartate (PALA) is unable to induce the T to R quaternary structural transition, causing only a small alteration of the scattering pattern. In contrast, addition of the activator ATP in the presence of PALA causes a significant increase in the scattering amplitude, indicating a large quaternary structural change, although the mutant does not entirely convert to the wild-type R structure. Attempts at modeling this new conformation using rigid body movements of the catalytic trimers and regulatory dimers did not yield a satisfactory solution. This indicates that intra- and/or interchain rearrangements resulting from the mutation bring about domain movements not accounted for in the simple model. Therefore, Asp-162 appears to play a crucial role in the cooperative structural transition and the heterotropic regulatory properties of ATCase.
Fetler
L
L
Laboratoire pour l'Utilisation du Rayonnement Electromagnétique (CNRS, CEA, MER), Université Paris-Sud, F-91898 Orsay Cedex, France.
Tauc
P
P
Baker
D P
DP
Macol
C P
CP
Kantrowitz
E R
ER
Vachette
P
P
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000494:Allosteric Regulation; D019943:Amino Acid Substitution; D001221:Aspartate Carbamoyltransferase / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000378:metabolism*; D004926:Escherichia coli; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D020836:Protein Structure, Quaternary / Q000187:drug effects; D013379:Substrate Specificity; D014965:X-Rays
D001224:Aspartic Acid; C013195:sparfosic acid; D000255:Adenosine Triphosphate; D001221:Aspartate Carbamoyltransferase; D010746:Phosphonoacetic Acid